Covance Not Cooling...
Health Care: Drugs
Synta Pharmaceuticals Inc. (SNTA: NASDAQ)
$7.50 0.01 | 0.13%
05/17/13 - 04:00 PM ET
Insider Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Net Insider Transaction | 189,250 | 270,681 | 195,681 | 81,431 | 0 | 4.02M | 5.09M |
| Shares Bought | 189,250 | 274,650 | 199,650 | 85,400 | 0 | 4.02M | 7.01M |
| Shares Sold | 0 | 3,969 | 3,969 | 3,969 | 0 | 0 | 1.91M |
Institutional Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Total Shares Held | 33.87M | 32.83M | 32.87M | 33.35M | 30.59M | 29.44M | 27.60M |
| Shares Bought | 16.81M | 8.20M | 8.24M | 8.20M | 10.22M | 9.59M | 5.56M |
| Shares Sold | 2.45M | 2.61M | 2.98M | 3.54M | 3.78M | 4.37M | 3.76M |
Portfolios with SNTA
- Portfolio NameUser Type
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks With Big Insider Buy...
- UserPharma
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks With Big Insider Buy...
- ContributorStocks With Big Insider Buy...
- Userinsider buying
Latest SNTA Headlines from TheStreet
- Synta Is a Run-Up Trade Into ASCO Lung Cancer Data 05.14.13 | 10:05 am
- Biotech Stock Mailbag: Synta, Zogenix, Sarepta, Amarin 05.10.13 | 07:05 am
- Synta Pharmaceuticals Becomes Oversold (SNTA) 05.08.13 | 04:05 pm
- Biotech Stock Mailbag: ASCO, Sarepta, Cel-Sci and Hate Mail! 04.26.13 | 08:04 am
- Insiders Trading GHDX ASCMA GNC SNTA 11.15.12 | 09:11 am
- The Next Big Thing in Biotech: Cancer Drugs
09.21.12 | 07:09 am - 5 Stocks Under $10 Set to Soar 09.20.12 | 01:09 pm
- 5 Stocks Under $10 Soaring Higher 09.13.12 | 02:09 pm
- 5 Stocks With Huge Insider Buying 07.11.12 | 10:07 am
- Insiders Trading SNTA, VMW, ENSG, AFG 07.03.12 | 10:07 am
Press Releases for SNTA
- Synta Provides Company Updates And Reports Fourth Quarter And Year-End 2012 Financial Results - Business Wire 03.14.13 | 07:03 am
- Synta Announces Appointment Of Sumant Ramachandra, M.D., Ph.D. As President, Research And Development - Business Wire 03.13.13 | 04:03 pm
- Synta To Host Conference Call And Webcast Of Fourth Quarter And Year-End 2012 Financial Results On March 14, 2013 - Business Wire 02.25.13 | 07:02 am
- Synta To Present At Upcoming Conferences - Business Wire 02.11.13 | 08:02 am
- Synta Pharmaceuticals Announces $60 Million Registered Direct Common Stock Offering - Business Wire 12.13.12 | 07:12 am
- Synta Pharmaceuticals Announces Proposed Registered Direct Offering Of Common Stock - Business Wire 12.12.12 | 04:12 pm
- Synta To Present At The Deutsche Bank 2012 DbAccess BioFEST - Business Wire 11.27.12 | 07:11 am
- Interim Results Of The Phase 2b/3 GALAXY Trial To Be Presented At The Fifth Asia Pacific Lung Cancer Conference - Business Wire 11.26.12 | 07:11 am
- Synta To Present At The Lazard Capital Markets 9th Annual Healthcare Conference - Business Wire 11.09.12 | 08:11 am
- Interim Results Of The Phase 2b GALAXY Trial To Be Presented At The Chemotherapy Foundation Symposium - Business Wire 11.07.12 | 08:11 am
Partner Headlines for SNTA
- BlackBerry Will Underperform and 4 More Analyst Notes to Looks At - Wall St. Cheat Sheet 04.01.13 | 04:04 am
- BlackBerry Will Underperform and 4 More Analyst Notes to Looks At - Wall St. Cheat Sheet 04.01.13 | 04:04 am
- Trius Therapeutics: New MSRA Treatment Could Bring Billions In Revenues - Seeking Alpha 03.05.13 | 09:03 am
- Insiders Love These 3 Highly Shorted Healthcare Stocks - Seeking Alpha 01.23.13 | 09:01 am
- UPDATE: Stifel Nicolaus Initiates Synta Pharmaceuticals at Hold; Enthusiasm Outpaces Expectations - Benzinga 08.30.12 | 01:08 pm
- Weekly CEO Buys Highlight: SNTA, MEI, PZG, MCHX, CMXI - GuruFocus 07.07.12 | 11:07 pm
- Vertex Pharmaceuticals CRASHES 16% with 3 NASDAQ Top Percentage Losers - Wall St. Cheat Sheet 06.29.12 | 10:06 am
- Healthcare Business Recap: Orexigen RIDES Arena, Anthera IMPLODES - Wall St. Cheat Sheet 06.28.12 | 08:06 am
- Analyst Says BUY Arena and 4 Equity Insights to Analyze Now - Wall St. Cheat Sheet 06.28.12 | 03:06 am
- New Lease Agreements for Alexandria - Analyst Blog - Zacks 06.08.12 | 05:06 pm
